{
    "2021-07-01": [
        [
            {
                "time": "2021-07-01",
                "original_text": "晚间重要公告2021年7月1日星期四",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药明康德",
                        "股价",
                        "市值",
                        "新高"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "中国PD-1药物的内卷化格局前瞻",
                "features": {
                    "keywords": [
                        "PD-1",
                        "药物",
                        "内卷化",
                        "格局"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "恒瑞医药现1笔大宗交易 共成交1,379.80万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "医药与健康护理行业月报：国内疫苗接种量高速增长 关注新冠疫苗出海机会",
                "features": {
                    "keywords": [
                        "疫苗",
                        "接种量",
                        "增长",
                        "新冠疫苗",
                        "出海"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "人民金融·创新药指数涨1.81% | 康泰生物、智飞生物正在研发新冠变异毒株疫苗，上半年15款国产创新药获批上市",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "新冠变异毒株疫苗",
                        "国产创新药",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "恒瑞医药(600276.SH)：HR17031注射液获美国FDA临床试验资格",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "HR17031",
                        "FDA",
                        "临床试验资格"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "医药生物行业月报：关注中报预期的投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报预期",
                        "投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "恒瑞医药：HR17031注射液获得美国FDA临床试验资格",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "HR17031",
                        "FDA",
                        "临床试验资格"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "恒瑞医药丢掉医药一哥宝座 经营面对两难",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "医药一哥",
                        "经营两难"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-30",
                "original_text": "A股融资融券日报：两融余额增加47.82亿元（6月30日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场资金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}